Other OTC - Delayed Quote USD

Acutus Medical, Inc. (AFIB)

0.0410 -0.0090 (-18.00%)
At close: May 14 at 3:59 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
7,164.0000
7,164.0000
3,031.0000
17,263.0000
8,464.0000
Cost of Revenue
10,301.0000
10,301.0000
4,941.0000
32,925.0000
15,889.0000
Gross Profit
-3,137.0000
-3,137.0000
-1,910.0000
-15,662.0000
-7,425.0000
Operating Expense
17,548.0000
17,548.0000
23,433.0000
100,206.0000
83,811.0000
Operating Income
-20,685.0000
-20,685.0000
-25,343.0000
-115,868.0000
-91,236.0000
Net Non Operating Interest Income Expense
-3,067.0000
-3,067.0000
-4,281.0000
-5,561.0000
-5,070.0000
Other Income Expense
11,894.0000
11,894.0000
58,472.0000
3,746.0000
-5,652.0000
Pretax Income
-11,858.0000
-11,858.0000
28,848.0000
-117,683.0000
-101,958.0000
Tax Provision
63.0000
63.0000
15.0000
--
23.0000
Net Income Common Stockholders
-81,663.0000
-81,663.0000
-39,616.0000
-117,683.0000
-101,981.0000
Diluted NI Available to Com Stockholders
-81,663.0000
-81,663.0000
-39,616.0000
-117,683.0000
-101,981.0000
Basic EPS
-2.81
--
-1.40
-4.11
-8.94
Diluted EPS
-2.81
--
-1.40
-4.11
-8.94
Basic Average Shares
29,095.2940
--
28,471.3890
28,654.3130
11,407.5420
Diluted Average Shares
29,095.2940
--
28,471.3890
28,654.3130
11,407.5420
Total Operating Income as Reported
-11,728.0000
-11,728.0000
41,043.0000
-112,122.0000
-91,333.0000
Total Expenses
27,849.0000
27,849.0000
28,374.0000
133,131.0000
99,700.0000
Net Income from Continuing & Discontinued Operation
-81,663.0000
-81,663.0000
-39,616.0000
-117,683.0000
-101,981.0000
Normalized Income
-21,317.2600
-21,317.2600
-29,608.5965
-121,429.0000
-97,855.0400
Interest Income
2,588.0000
2,588.0000
868.0000
116.0000
436.0000
Interest Expense
5,655.0000
5,655.0000
5,149.0000
5,677.0000
5,506.0000
Net Interest Income
-3,067.0000
-3,067.0000
-4,281.0000
-5,561.0000
-5,070.0000
EBIT
-6,203.0000
-6,203.0000
33,997.0000
-112,006.0000
-96,452.0000
EBITDA
-5,329.0000
-5,329.0000
35,205.0000
-105,116.0000
-92,548.0000
Reconciled Cost of Revenue
10,301.0000
10,301.0000
4,941.0000
32,925.0000
15,889.0000
Reconciled Depreciation
874.0000
874.0000
1,208.0000
6,890.0000
3,904.0000
Net Income from Continuing Operation Net Minority Interest
-11,921.0000
-11,921.0000
28,833.0000
-117,683.0000
-101,981.0000
Total Unusual Items Excluding Goodwill
11,894.0000
11,894.0000
58,472.0000
3,746.0000
-5,652.0000
Total Unusual Items
11,894.0000
11,894.0000
58,472.0000
3,746.0000
-5,652.0000
Normalized EBITDA
-17,223.0000
-17,223.0000
-23,267.0000
-108,862.0000
-86,896.0000
Tax Rate for Calcs
0.0002
0.0002
0.0000
--
0.0003
Tax Effect of Unusual Items
2,497.7400
2,497.7400
30.4035
--
-1,526.0400
12/31/2020 - 8/6/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NUWE Nuwellis, Inc.
0.2304
-7.17%
 
TIVC Tivic Health Systems, Inc.
0.5000
+3.35%
 
SINT Sintx Technologies, Inc.
0.0550
+41.75%
 
BIOL BIOLASE, Inc.
0.1540
-14.87%
 
HSDT Helius Medical Technologies, Inc.
1.5600
-8.24%
 
NUVO Holdco Nuvo Group D.G Ltd
2.2200
-5.53%
 
TMCI Treace Medical Concepts, Inc.
5.0000
+10.38%
 
AEMD Aethlon Medical, Inc.
0.8501
-14.47%
 
SRTS Sensus Healthcare, Inc.
5.30
-1.85%
 
HSCS Heart Test Laboratories, Inc.
0.0791
+12.04%